Trinity Biotech's market cap is currently $8.74M. The company's EPS TTM is $-2.263; its P/E ratio is ―; Trinity Biotech is scheduled to report earnings on April 2, 2025, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 56.83M	$ 74.78M	$ 92.97M	$ 101.98M	$ 90.44M
Gross Profit	$ 19.45M	$ 22.05M	$ 38.08M	$ 48.58M	$ 38.12M
Operating Income	$ -27.05M	$ -10.91M	$ 13.15M	$ 19.11M	$ 872.00K
EBITDA	$ -24.10M	$ -16.71M	$ 10.59M	$ 21.52M	$ -19.52M
Net Income	$ -24.02M	$ -41.00M	$ 875.00K	$ -6.01M	$ -4.07M
Balance Sheet
Cash & Short-Term Investments	$ 3.69M	$ 6.58M	$ 25.91M	$ 27.33M	$ 16.40M
Total Assets	$ 59.44M	$ 92.10M	$ 118.89M	$ 130.40M	$ 131.07M
Total Debt	$ 67.43M	$ 58.26M	$ 99.16M	$ 104.34M	$ 82.03M
Net Debt	$ 63.74M	$ 51.68M	$ 73.25M	$ 77.01M	$ 65.63M
Total Liabilities	$ 83.38M	$ 94.28M	$ 119.21M	$ 132.62M	$ 126.36M
Stockholders' Equity	$ -23.95M	$ -2.18M	$ -319.00K	$ -2.22M	$ 4.71M
Cash Flow
Free Cash Flow	$ -14.26M	$ -6.90M	$ 4.55M	$ 13.56M	$ -9.88M
Operating Cash Flow	$ -11.56M	$ -921.00K	$ 13.24M	$ 23.75M	$ 5.47M
Investing Cash Flow	$ 24.76M	$ -5.98M	$ -8.69M	$ -10.20M	$ -15.36M
Financing Cash Flow	$ -16.04M	$ -12.32M	$ -6.02M	$ -2.72M	$ -4.00M

Currency in USD

Trinity Biotech Earnings and Revenue History

Income Statement >

Trinity Biotech Debt to Assets

Balance Sheet >

Trinity Biotech Cash Flow

Cash Flow >

Trinity Biotech Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing